gvtcx

NHS National Framework Agreement for the Supply of Adalimumab

NHS England Published 7 May 2019 Contracts Finder
The value below is a framework or dynamic market ceiling: the maximum that could be spent across all call-offs, not the value of a single contract. Aggregate figures on this site exclude these to avoid double counting.

key details

Value£164,000,000
Statuscomplete
Category (CPV) 33600000
RegionNorth East, North West, Yorkshire and the Humber, East Midlands, West Midlands, East of England, London, South East, South West
Deadline22 Oct 2018
Contract start1 Dec 2018
Contract end30 Nov 2019
Procedureopen
SME suitableYes
OCIDocds-b5fd17-b7814246-81df-43d6-8226-07806a9879f3

Awards (5)

This procurement was awarded to 5 suppliers. Values shown are per-award; the notice total is £164,000,000.

SupplierValueDateStatus
Abbvie Ltd shared £159,371,013 1 Dec 2018 active
Amgen Ltd shared £159,371,013 1 Dec 2018 active
Biogen Idec UK Limited shared £159,371,013 1 Dec 2018 active
Mylan shared £159,371,013 1 Dec 2018 active
Sandoz Ltd shared £159,371,013 1 Dec 2018 active

description

NHS National Framework Agreement for Adalimumab Injection,

Framework Period: 1 December 2018 - 30 November 2019 with an option to extend (at the Authority's discretion) for a period or periods up to a total of 24 months

Tender Reference: CM/PHR/18/5567

documents

Documents are linked, not mirrored. They are served by the publishing authority and may require registration.

notice history

2 notices published against this procurement.

PublishedTypeRegimeNotice
19 Sept 2018 Tender (tender) · d8696ac8-ee62-4da9-93fa-611165862f95-241724
7 May 2019 Award (award) · 05c544dc-9e6f-452d-87c1-bf00f3ce73ac-287891

more from NHS England

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.